Legrand C, Caen J P
Haemostasis. 1978;7(6):339-51. doi: 10.1159/000214278.
Normal and thrombasthenic platelet membranes are able to specifically bind 14C-ADP (12). According to the concentration of ADP present in the medium, 'high affinity binding sites' (Ka = 0.5 X 10(6) M-1 and 'low affinity-binding sites' (Ka = 0.05 X 10(6) M-1) can be recognized. In the present study, dissociation of ADP from the 'high affinity binding sites' was measured with six normal and with three thrombasthenic platelet membrane preparations. A 1:100 dilution was used to dissociate the membrane-bound 14C-ADP and the kinetics of the dissociation was determined. The same profile of dissociation (with T 1/2 = 4--10 min at 37 degrees C) was observed using normal or thrombasthenic membranes. With both preparations, the rate of dissociation was increased (up to T 1/2 = 1--3 min) when unlabelled ADP (at concentration higher than 10(-5) M) was added in the diluting medium. The results confirm the presence of normal ADP binding sites on thrombasthenic platelet membrane and possibly suggest the existence of cooperative interactions between the sites on normal as well as on thrombasthenic membranes.
正常血小板膜和血小板无力症患者的血小板膜均能够特异性结合14C-ADP(12)。根据培养基中ADP的浓度,可以识别出“高亲和力结合位点”(Ka = 0.5×10⁶ M⁻¹)和“低亲和力结合位点”(Ka = 0.05×10⁶ M⁻¹)。在本研究中,用六种正常血小板膜制剂和三种血小板无力症患者的血小板膜制剂测量了ADP从“高亲和力结合位点”的解离情况。使用1:100稀释液来解离膜结合的14C-ADP,并测定解离动力学。使用正常膜或血小板无力症患者的膜观察到相同的解离曲线(在37℃下T1/2 = 4 - 10分钟)。对于这两种制剂,当在稀释培养基中加入未标记的ADP(浓度高于10⁻⁵ M)时,解离速率增加(高达T1/2 = 1 - 3分钟)。结果证实血小板无力症患者的血小板膜上存在正常的ADP结合位点,并可能提示正常膜和血小板无力症患者的膜上这些位点之间存在协同相互作用。